FIELD: medicine.
SUBSTANCE: invention refers to medicine and biotechnology and concerns treating an antibacterial agent for treating gastrointestinal diseases, preferentially acute intestinal infections, including unexplained. The declared preparation represents a mixture of an antibiotic and probiotic, wherein the antibiotic is presented by ofloxacin, while the probiotic is a bifidus bacterial biomass in the following ratio, mg/capsule: ofloxacin - 200 mg, bifidus bacterial biomass - 200 mg containing min. 2×107 CFU/g living microorganisms.
EFFECT: invention enables reducing the length of recovery in the patients suffering acute intestinal infection considerably.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED ANTIBACTERIAL PREPARATION FOR TREATING ACUTE INTESTINAL INFECTIONS | 2012 |
|
RU2502509C1 |
| COMBINED ANTIBACTERIAL PREPARATION FOR TREATING ACUTE INTESTINAL INFECTIONS | 2012 |
|
RU2503451C1 |
| METHOD FOR PREPARING COMBINED ANTIBACTERIAL PREPARATION FOR TREATING ACUTE INTESTINAL INFECTIONS | 2012 |
|
RU2513204C1 |
| METHOD OF TREATMENT OF PATIENTS WITH ACUTE AND CHRONIC INTESTINAL DISEASES, REMEDY AND ITS FORM | 1998 |
|
RU2164143C2 |
| METHOD FOR DISAGGREGATION OF BIFIDUS BACTERIA CULTURE FLUID | 2019 |
|
RU2731071C1 |
| METHOD OF CONTACT-SORBTION DEHYDRATATION OF HIGH-DISPERSE BIOLOGICALLY ACTIVE MATERIALS | 2009 |
|
RU2455349C2 |
| METHOD FOR DISPERSING CULTURE LIQUID OF BIFIDOBACTERIA | 2019 |
|
RU2731063C1 |
| METHOD FOR SIMULATING INTESTINAL DYSBACTERIOSIS IN LABORATORY ANIMALS | 2011 |
|
RU2477894C1 |
| ANTIBACTERIAL AGENTS AND METHOD FOR TREATING INTESTINAL YERSINIOSIS OR PSEUDOTUBERCULOSIS, OR COLIBACILLOSIS | 2016 |
|
RU2614730C1 |
| AGENT FOR REDUCTION OF INTESTINAL MICROBIOCENOSIS IN CASE OF DYSBIOSIS | 2015 |
|
RU2593584C1 |
